Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
Portuguese (Brazilian)

Lay Summaries and Lay Summary Videos

  • BI 443651 - Cystic Fibrosis , Healthy
    Clinical Study Number 1363.2
    Study Indication Cystic Fibrosis ; Healthy
    Product BI 443651
    Generic Name BI 443651
    Lab Code BI 443651
    Clinical Phase Ib
    Study Title

    A Phase Ib, multicentre, double blind, randomised, two-part study, first part multiple rising dose and second part two-way cross-over, to assess safety, tolerability, efficacy and pharmacokinetics of BI 443651 compared to placebo via Respimat® in healthy volunteers and cystic fibrosis subjects

    Study Document
    Lay summary 1363.2 english
    Lay summary 1363.2 german
  • TRIJARDY® XR - Healthy
    Clinical Study Number 1361-0011
    Study Indication Healthy
    Product TRIJARDY® XR
    Generic Name Empagliflozin + Linagliptin + Metformin
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of a low strength fixed dose combination tablet of empagliflozin/linagliptin/metformin extended release compared to the free combination of empagliflozin, linagliptin, and metformin extended release tablets following oral administration in healthy male and female subjects (an open-label, randomised, single-dose, two-period, two-sequence crossover study)

    Study Document
    Lay summary 1361-0011 english